Solco Biomedical Co., Ltd. Stock

Equities

A043100

KR7043100007

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 18:00:00 2024-04-29 EDT 5-day change 1st Jan Change
435 KRW +1.40% Intraday chart for Solco Biomedical Co., Ltd. +2.35% +4.57%

Financials

Sales 2022 23.4B 17.15M 23.44M Sales 2023 26.88B 19.7M 26.93M Capitalization 27.61B 20.24M 27.66M
Net income 2022 -7.38B -5.41M -7.4M Net income 2023 -19.97B -14.64M -20.01M EV / Sales 2022 1.86 x
Net Debt 2022 12.84B 9.41M 12.87M Net Debt 2023 19.15B 14.04M 19.19M EV / Sales 2023 1.74 x
P/E ratio 2022
-3.96 x
P/E ratio 2023
-1.38 x
Employees 112
Yield 2022 *
-
Yield 2023
-
Free-Float 86.76%
More Fundamentals * Assessed data
Dynamic Chart
Solco Biomedical Co., Ltd. announced that it expects to receive KRW 13 billion in funding from MDS Intelligence Inc. CI
Solco Biomedical Co., Ltd. announced that it has received KRW 900 million in funding CI
Solco Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
CTL Biotech Co., Ltd announced that it expects to receive KRW 120 million in funding from Solco Biomedical Co., Ltd. CI
Gilon Co., Ltd. announced that it has received KRW 500 million in funding from Solco Biomedical Co., Ltd. CI
Gilon Co., Ltd. announced that it expects to receive KRW 500 million in funding from Solco Biomedical Co., Ltd. CI
Solco Biomedical Co., Ltd. announced that it has received KRW 2.1 billion in funding CI
Solco Biomedical Co., Ltd. announced that it has received KRW 1.5 billion in funding CI
Solco Biomedical Co., Ltd. announced that it has received KRW 3 billion in funding from CAPE Investment & Securities Co.,Ltd., Investment Arm and another investor CI
Solco Biomedical Co., Ltd. announced that it expects to receive KRW 1.5 billion in funding CI
Bionet Co. Ltd. announced that it has received KRW 1.75 billion in funding from Solco Biomedical Co., Ltd. CI
Solco Biomedical Co. Ltd. announced that it has received KRW 3.5 billion in funding CI
Solco Biomedical Co. Ltd. announced that it expects to receive KRW 3.5 billion in funding CI
Solco Biomedical Co. Ltd. announced that it has received KRW 3 billion in funding from Sejong Mutual Savings Bank Co.,Ltd., Investment Arm. CI
Solco Biomedical Co. Ltd. announced that it expects to receive KRW 3 billion in funding from Sejong Mutual Savings Bank Co.,Ltd., Investment Arm. CI
More news
1 day+1.40%
1 week+2.35%
Current month-15.37%
1 month-15.37%
3 months+23.23%
6 months-5.43%
Current year+4.57%
More quotes
1 week
423.00
Extreme 423
464.00
1 month
414.00
Extreme 414
517.00
Current year
346.00
Extreme 346
683.00
1 year
346.00
Extreme 346
683.00
3 years
346.00
Extreme 346
2 175.00
5 years
346.00
Extreme 346
2 175.00
10 years
346.00
Extreme 346
6 692.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 99-02-24
Director/Board Member 52 -
Comptroller/Controller/Auditor 41 21-03-28
Members of the board TitleAgeSince
Chief Executive Officer 53 99-02-24
Director/Board Member 52 -
Director/Board Member 50 -
More insiders
Date Price Change Volume
24-05-02 431 -0.92% 83,038
24-04-30 435 +1.40% 166,791
24-04-29 429 +0.70% 128,204
24-04-26 426 -1.39% 201,579
24-04-25 432 +0.47% 199,981

End-of-day quote Korea S.E., April 29, 2024

More quotes
Solco Biomedical Co., Ltd. is a Korea-based company mainly engaged in the manufacture of medical equipment and healthcare products. The Company operates its business through two divisions: medical equipment division, which produces implants used in trauma, spine, hip joints and knee joints, and surgical instruments and disposable appliances, such as forceps, scissors, needle holders, hemostatic forceps, intestinal forceps, retractors, hooks, trocars, suction tubes, mouth gags, vein strippers, probes and other products, and healthcare division, which produces household therapy equipment, such as heating mats, water ionizers, air cleaners and others. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A043100 Stock